Lepidine B & E as new target inhibitors from Lepidium sativum seeds against four enzymes of the pathogen Candida albicans: in vitro and in silico studies.

CONCLUSION: Through this work, we propose Lepidine B & E as potent antifungal drugs. PMID: 30987578 [PubMed - as supplied by publisher]
Source: Endocrine, Metabolic and Immune Disorders Drug Targets - Category: Drugs & Pharmacology Tags: Endocr Metab Immune Disord Drug Targets Source Type: research